OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies
Dilipkumar Pal, Khushboo Raj, Shyam Sundar Nandi, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2808-2808
Open Access | Times Cited: 20

Showing 20 citing articles:

Molecular Precision Medicine: Multi-Omics-Based Stratification Model for Acute Myeloid Leukemia
Teng Wang, Siyuan Cui, Chunyi Lyu, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36155-e36155
Open Access | Times Cited: 6

Ursolic Acid’s Alluring Journey: One Triterpenoid vs. Cancer Hallmarks
Youness Limami, Aline Pinon, Hicham Wahnou, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7897-7897
Open Access | Times Cited: 14

Cancer Stem Cells from Definition to Detection and Targeted Drugs
Barbara Ruszkowska-Ciastek, Katarzyna Kwiatkowska, Dorinda Marques‐da‐Silva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3903-3903
Open Access | Times Cited: 5

Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors
Sultan Abda Neja, Wan Mohaiza Dashwood, Roderick H. Dashwood, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 396-396
Open Access | Times Cited: 4

Synthesis of Biopolymers and Characterization
Dilipkumar Pal, Supriyo Saha
(2025), pp. 91-108
Closed Access

Coumarins in Anticancer Therapy: Mechanisms of Action, Potential Applications and Research Perspectives
Tomasz Kubrak, Anna Makuch‐Kocka, David Aebisher
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 595-595
Open Access

Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access

Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword
Sina Kamrani, Reza Naseramini, Pouria Khani, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access

Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2125-2142
Closed Access | Times Cited: 2

Isoxazole compounds: unveiling the synthetic strategy, In-silico SAR & Toxicity studies and future perspective as PARP inhibitor in cancer therapy
Udita Malik, Dilipkumar Pal
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116898-116898
Closed Access | Times Cited: 2

Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas
Ruxandra Irimia, Pier Paolo Piccaluga
Cancers (2024) Vol. 16, Iss. 19, pp. 3359-3359
Open Access | Times Cited: 2

Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia
Tong Xiao, Zhigang Chen, Yutong Xie, et al.
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 2

A Case report on subdural hematoma in a 60yr old male patient with ESRD
K. M. Sunanda, Bhargava Narendra J
World Journal of Current Medical and Pharmaceutical Research (2024), pp. 13-16
Open Access

Prescribing patterns and analyzing the usage of corticosteroid therapy at tertiary care hospital
Pavithra CH, C M Mahesh, Prasanth Kumar D, et al.
UPI Journal of Pharmaceutical Medical and Health Sciences (2024), pp. 1-8
Open Access

Star wars against leukemia: attacking the clones
Monika M. Toma, Tomasz Skórski
Leukemia (2024)
Open Access

Exploring the potential of Andrographis paniculata for developing novel HDAC inhibitors: an in silico approach
Debalina Das, Ritesh Banerjee, Maumita Bandyopadhyay, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-13
Closed Access | Times Cited: 1

Host-directed therapies modulating innate immunity against infection in hematologic malignancies
Qiong Wang, Kristján Hermannsson, Emeline Masson, et al.
Blood Reviews (2024), pp. 101255-101255
Open Access

Page 1

Scroll to top